Estimating the savings associated with a migraine-free life: results from the Spanish Atlas

Irimia, P. ; Garrido-Cumbrera, M. ; Santos-Lasaosa, S. (Universidad de Zaragoza) ; Braçe, O. ; Colomina, I. ; Blanch, C. ; Pozo-Rosich, P.

Resumen: Background and purpose: Migraine is a common and costly neurological disorder. The aims of this study were to quantify the costs of chronic (CM) and episodic migraine (EM) in Spain, evaluating the impact of psychiatric comorbidities and disability, and to estimate the economic savings associated with reducing the number of migraine-days by 50%.
Methods: This was an observational, cross-sectional analysis of data from migraine patients who participated in the Spanish Migraine Atlas. The participants were invited to complete a structured questionnaire including the following scales: the Headache Needs Assessment, the Hospital Anxiety and Depression Scale, and the Migraine Disability Assessment Scale (MIDAS).
Results: A total of 475 patients were included, of whom 187 had CM (39.4%). Total costs per patient/year were: €16 578.2 ± €34 568.1 for CM and €6227.8 ± €6515.7 for EM. A higher degree of disability, according to MIDAS, significantly increased the total cost of migraine, while the presence of psychiatric comorbidity increased costs for EM patients only. A reduction of 1 migraine-day per month decreased average total costs by €744.14 per patient/year for EM and €663.20 per patient/year for CM, while a reduction in the number of migraine-days by 50% would result in economic savings of €2232.44 per patient/year (R2 = 0.927) for EM and €6631.99 per patient/year (R2 = 0.886) for CM.
Conclusions: The costs associated with migraine were driven by migraine frequency and the degree of disability, whereas psychiatric comorbidity only influenced the cost of EM. These results highlight the need to optimize migraine management to reduce the economic migraine burden. Future studies are needed to confirm our results.

Idioma: Inglés

DOI: 10.1111/ene.14431

Año: 2020

Publicado en: EUROPEAN JOURNAL OF NEUROLOGY 27, 12 (2020), 2616-2624
ISSN: 1351-5101

Factor impacto JCR: 6.089 (2020)

Categ. JCR: NEUROSCIENCES rank: 53 / 273 = 0.194 (2020) - Q1 - T1
Categ. JCR: CLINICAL NEUROLOGY rank: 30 / 208 = 0.144 (2020) - Q1 - T1

Factor impacto SCIMAGO: 1.881 - Neurology (clinical) (Q1) - Neurology (Q1)

Tipo y forma: Artículo (PostPrint)

Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)